Overview

Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.

Status:
Not yet recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double blind, placebo-controlled, parallel design study to evaluate the efficacy and safety of TPN171H in men with erectile dysfunction.
Phase:
Phase 3
Details
Lead Sponsor:
Vigonvita Life Sciences